Phibro Animal Health | PAHC - 贸易债权人

金融业

USD

USD 1.5B

现金及等价物

USD 61.42M

USD 240.42M

USD 935.51M

USD 316.47M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 385.48M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.57B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 534.88M

贸易债权人

USD 127.31M

应收帐款人

USD 215.87M

	贸易债权人	更改		日
Align Technology	USD 109.84M		13.88M	2026-06
ANI Pharmaceuticals	USD 73.83M		4.14M	2026-06
Aurora Cannabis	CAD 9.31M		58.72M	2026-03
Bristol-Myers Squibb	USD 4.16B		76M	2026-06
Canopy Growth	CAD 34.82M		14.85M	2026-03
Corcept Therapeutics	USD 14.91M		18.4M	2026-06
Eli Lilly	USD 6.11B		1.08B	2026-06
Henry Schein	USD 1.14B		92M	2026-06
Idexx Laboratories	USD 129.1M		877K	2026-06
Knight Therapeutics	CAD 125.76M		7.63M	2025-12
Merck	USD 3.83B		36M	2026-06
Nektar Therapeutics	USD 10.03M		744K	2026-03
Pacira	USD 17.51M		3.5M	2026-06
Phibro Animal Health	USD 127.31M		2.33M	2026-06
Prestige Brands	USD 36.85M		14.06M	2026-06
Supernus Pharmaceuticals	USD 5.59M		4.58M	2026-06
Zoetis	USD 452M		55M	2026-06